- Home
- CNR vs ACLX Comparison
CNR vs ACLX Comparison
Compare CNR & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNR
- ACLX
- Stock Information
- Founded
- CNR 1864
- ACLX 2015
- Country
- CNR United States
- ACLX United States
- Employees
- CNR N/A
- ACLX N/A
- Industry
- CNR Coal Mining
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- CNR Energy
- ACLX Health Care
- Exchange
- CNR Nasdaq
- ACLX Nasdaq
- Market Cap
- CNR 3.7B
- ACLX 3.8B
- IPO Year
- CNR N/A
- ACLX 2022
- Fundamental
- Price
- CNR $72.87
- ACLX $71.14
- Analyst Decision
- CNR Strong Buy
- ACLX Strong Buy
- Analyst Count
- CNR 4
- ACLX 14
- Target Price
- CNR $96.50
- ACLX $114.75
- AVG Volume (30 Days)
- CNR 812.9K
- ACLX 420.2K
- Earning Date
- CNR 08-05-2025
- ACLX 08-11-2025
- Dividend Yield
- CNR 0.55%
- ACLX N/A
- EPS Growth
- CNR N/A
- ACLX N/A
- EPS
- CNR 3.30
- ACLX N/A
- Revenue
- CNR $2,663,948,000.00
- ACLX $76,809,000.00
- Revenue This Year
- CNR $87.76
- ACLX N/A
- Revenue Next Year
- CNR $9.59
- ACLX $108.81
- P/E Ratio
- CNR $22.05
- ACLX N/A
- Revenue Growth
- CNR 11.29
- ACLX N/A
- 52 Week Low
- CNR $58.19
- ACLX $47.86
- 52 Week High
- CNR $134.59
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- CNR N/A
- ACLX 58.77
- Support Level
- CNR N/A
- ACLX $69.30
- Resistance Level
- CNR N/A
- ACLX $74.43
- Average True Range (ATR)
- CNR 0.00
- ACLX 2.53
- MACD
- CNR 0.00
- ACLX 0.02
- Stochastic Oscillator
- CNR 0.00
- ACLX 58.41
About CNR Core Natural Resources Inc. Common Stock
Core Natural Resources Inc is a producer and exporter of coal. The company owns and operates longwall mining operations in the nation and export terminals on the Eastern seaboard. The principal activity involves mining, preparation, and marketing of thermal coal, sold to power generators.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.